Algeria Pharmaceuticals and Healthcare Report Q3 2009

Executive Summary ........................................5
SWOT Analysis................................................6
Algeria Pharmaceuticals And Healthcare Industry SWOT ................................... 6
Pharmaceutical Business Environment Ratings ..........................................7
Table: Middle East And North Africa – Regional Pharmaceutical Business Environment Ratings for Q309........ 7
Limits Of Potential Returns................................... 8
Risks To Realisation Of Returns ........................... 8
Algeria – Market Summary ............................10
Regulatory Regime........................................11
Trade Agreements............................................... 11
Intellectual Property Environment...................... 12
Intellectual Property Shortcomings .................... 13
Pricing And Reimbursement Regime................... 15
Industry Trends And Developments ............16
Epidemiology...... 16
Table Algeria – Top 10 Causes Of Death For All Ages (2002)........................... 16
Healthcare Sector ............................................... 17
Healthcare Sector Reforms ................................. 18
Domestic Pharmaceutical Sector........................ 18
Recent Domestic Pharmaceutical Sector Developments ..................................... 20
Foreign Pharmaceutical Sector .......................... 21
Recent Foreign Pharmaceutical Sector Developments ....................................... 22
Pharmaceutical Wholesale ................................. 23
Pharmaceutical Retail ........................................ 24
Biotechnology And Research .............................. 25
Medical Devices.................................................. 25
Industry Forecast Scenario ...........................26
Overall Market Forecast..................................... 26
Table: Algeria - Drug Expenditure Indicators, Historical Data and Forecasts ... 27
Key Growth Factors – Industry........................... 28
Table: Algeria - Health Expenditure Indicators, Historical Data and Forecasts................................................. 29
Key Growth Factors – Macroeconomic Forecast .......................................30
Table: Algeria – Economic Activity .................... 31
Prescription Market Forecast ............................. 32
Table: Algeria - Prescription Market Indicators, Historical Data and Forecasts (DZDmn unless otherwise stated).......................................... 33
Patented Drug Market Forecast ......................... 34
Table: Algeria - Patented Drug Market Indicators, Historical Data and Forecasts............................................ 34
Generics Market Forecasts................................. 35
Table: Algeria - Generics Market Indicators, Historical Data and Forecasts..... 35
OTC Market Forecast......................................... 36
Table: Algeria - OTC Market Indicators, Historical Data and Forecasts (DZDmn unless otherwise stated)...... 37
Pharmaceutical Trade Forecasts........................ 38
Table: Algeria - Pharmaceutical Trade Indicators, Historical Data and Forecasts (US$mn)............................. 39
Other Healthcare Data Forecasts....................... 39
Table: Algeria – Other Healthcare Indicators, Historical Data And Forecasts... 39
Key Risks To BMI’s Forecast Scenario............... 40
Key Risks To BMI’s Forecast Scenario............... 40
Competitive Landscape................................41
Table Leading Pharmaceutical Companies In Algeria ....................................... 42
Company Profiles..........................................43
Leading Multinationals............................................ 43
Sanofi-Aventis..... 43
GlaxoSmithKline (GSK)...................................... 45
Pfizer .................. 46
Novartis .............. 48
Merck & Co ........ 49
Leading Indigenous Manufacturer........................... 50
Groupe Saidal..... 50
Country Snapshot: Algeria Demographic Data...........................................52
Section 1: Population.......................................... 52
Table: Demographic Indicators, 2005-2030....... 52
Table: Rural/Urban Breakdown, 2005-2030 ...... 53
Section 2: Education And Healthcare................. 53
Table: Education Levels, 2002-2025 .................. 53
Table: Healthcare – Vital Statistics, 2005-2030 ................................................. 53
Section 3: Labour Market And Spending Power ................................................. 54
Table: Employment Indicators, 2001-2006......... 54
Table: Consumer Expenditure, 2000-2012 (US$) ............................................... 55
BMI Forecast Modelling................................56
How We Generate Our Pharmaceutical Industry Forecasts .................................... 56
Pharmaceutical Business Environment Ratings Methodology ................................. 57
Ratings Overview................................................ 57
Table: Pharmaceutical Business Environment Indicators .................................. 58
Weighting............ 59
Table: Weighting Of Components....................... 59
Sources .................... 59